Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2016 Sep 16;68(10):1554–1559. doi: 10.1002/acr.22859

Table 2.

Multivariate models assessing the association of selected phenotypic features of Sjögren’s syndrome with salivary and lacrimal gland function outcome measures

A. “Unstimulated whole saliva flow <0.1 ml/min vs ≥0.1 ml/min”
Phenotypic feature Unadjusted OR P value Adjusted OR (95% CI) P value
Age ≥60 years 2.04 (1.60–2.62) <0.0001 2.12 (1.64–2.77) <0.0001
Female gender 2.14 (1.39–3.30) 0.0005 1.92 (1.23–3.02) 0.0043
Anti-SSA and/or -SSB 0.96 (0.74–1.26) 0.7909 1.35 (0.99–1.82) 0.0513
Focus score≥2 2.59 (2.07–3.25) <0.0001 2.50 (1.98–3.15) <0.0001
ACA 13.42 (5.54–44.18) <0.0001 12.24 (4.91–41.02) <0.0001
B. “ Schirmer’s <5 mm/5 min vs ≥5 mm/5 min”
Phenotypic feature Unadjusted OR P value Adjusted OR (95% CI) P value
Age ≥60 years 1.40 (1.11–1.77) 0.0041 1.46 (1.14–1.86) 0.0022
Female gender 1.02 (0.66–1.58) 0.9229 1.18 (0.76–1.84) 0.4694
Anti-SSA and/or -SSB 1.28 (0.98–1.66) 0.0663 1.55 (1.17–2.07) 0.0026
Focus score ≥2 2.02 (1.62–2.52) <0.0001 1.97 (1.58–2.46) <0.0001
ACA 2.21 (1.37–3.66) 0.0009 2.52 (1.50–4.36) 0.0004

Abbreviations: ACA: anticentromere antibody